Acurx Pharmaceuticals Inc

Research Acurx Pharmaceuticals Inc (ACXP) on Bullrun: market cap USD 5.69M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerACXP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.69M
• Financial periodFY2025
• Net income-USD 7.97M

Valuation Snapshot

latest market cap is USD 5.69M.

About Acurx Pharmaceuticals Inc

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.

Frequently asked questions

What is Acurx Pharmaceuticals Inc's market cap?

Acurx Pharmaceuticals Inc's market capitalization is USD 5.69M.

What does Acurx Pharmaceuticals Inc do?

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.